CATHEREX

In April 2010, Medigene assigned its development program of oncolytic (cancer-killing) herpes simplex viruses (oHSV), to Catherex, Inc.

#More

CATHEREX

Industry:

Health Care Medical

Status:

Active

More informations about "Catherex" on Search Engine